Clinical Trial Update: Belimumab in Autoimmune Hepatitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating belimumab for autoimmune hepatitis is currently recruiting in Toronto, led by University Health Network.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Hepatitis

Drugs mentioned

• Belimumab (belimumab)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Autoimmune Hepatitis | Phase 2 | Status: RECRUITING